Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CF Industries Holdings, Inc. stock logo
CF
CF Industries
$79.71
-0.2%
$81.24
$69.13
$98.25
$13.51B0.992.08 million shs3.53 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.30
-1.6%
$25.98
$24.26
$31.54
$137.79B0.6139.31 million shs53.41 million shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CF Industries Holdings, Inc. stock logo
CF
CF Industries
+0.16%+4.03%+2.34%-7.10%-3.86%
Pfizer Inc. stock logo
PFE
Pfizer
+0.84%-1.84%-5.65%-7.07%-10.24%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CF Industries Holdings, Inc. stock logo
CF
CF Industries
4.6182 of 5 stars
3.13.02.50.04.22.53.1
Pfizer Inc. stock logo
PFE
Pfizer
4.9717 of 5 stars
3.33.04.24.23.33.33.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CF Industries Holdings, Inc. stock logo
CF
CF Industries
2.14
Hold$89.8612.74% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.63
Moderate Buy$31.9231.40% Upside

Current Analyst Ratings Breakdown

Latest CF and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/27/2025
Pfizer Inc. stock logo
PFE
Pfizer
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/18/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/13/2025
CF Industries Holdings, Inc. stock logo
CF
CF Industries
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$86.00
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/5/2025
CF Industries Holdings, Inc. stock logo
CF
CF Industries
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$100.00 ➝ $95.00
2/25/2025
CF Industries Holdings, Inc. stock logo
CF
CF Industries
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$100.00 ➝ $90.00
2/24/2025
CF Industries Holdings, Inc. stock logo
CF
CF Industries
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Underperform ➝ Sector Underperform$88.00 ➝ $81.00
2/24/2025
CF Industries Holdings, Inc. stock logo
CF
CF Industries
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$84.00 ➝ $84.00
2/20/2025
CF Industries Holdings, Inc. stock logo
CF
CF Industries
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$92.00 ➝ $90.00
2/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$33.00 ➝ $33.00
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CF Industries Holdings, Inc. stock logo
CF
CF Industries
$5.94B2.28$12.22 per share6.52$43.63 per share1.83
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.17$3.81 per share6.38$15.81 per share1.54
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CF Industries Holdings, Inc. stock logo
CF
CF Industries
$1.53B$6.7711.7713.600.3720.52%15.50%8.87%5/7/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4117.238.020.6412.62%19.47%8.09%4/29/2025 (Estimated)

Latest CF and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2025N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.67N/AN/AN/A$14.43 billionN/A
2/19/2025Q4 2024
CF Industries Holdings, Inc. stock logo
CF
CF Industries
$1.49$1.89+$0.40$1.89$1.50 billion$1.52 billion
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CF Industries Holdings, Inc. stock logo
CF
CF Industries
$2.002.51%+18.56%29.54%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.08%+2.50%121.99%16 Years

Latest CF and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/30/2025
CF Industries Holdings, Inc. stock logo
CF
CF Industries
quarterly$0.502.17%2/14/20252/14/20252/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CF Industries Holdings, Inc. stock logo
CF
CF Industries
0.39
3.08
2.52
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73

Institutional Ownership

CompanyInstitutional Ownership
CF Industries Holdings, Inc. stock logo
CF
CF Industries
93.06%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
CF Industries Holdings, Inc. stock logo
CF
CF Industries
0.42%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
CompanyEmployeesShares OutstandingFree FloatOptionable
CF Industries Holdings, Inc. stock logo
CF
CF Industries
2,700169.54 million173.29 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
83,0005.67 billion5.66 billionOptionable

Recent News About These Companies

Is Pfizer Stock a Buy?
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Shares Up 0.6% - Time to Buy?
Pfizer Inc. stock logo
Pfizer (NYSE:PFE) Sets New 1-Year Low - What's Next?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CF Industries stock logo

CF Industries NYSE:CF

$79.70 -0.13 (-0.16%)
Closing price 03:59 PM Eastern
Extended Trading
$79.43 -0.27 (-0.35%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CF Industries Holdings, Inc., together with its subsidiaries, engages in the manufacture and sale of hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities in North America, Europe, and internationally. It operates through Ammonia, Granular Urea, UAN, AN, and Other segments. The company's principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. It also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products. The company primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. CF Industries Holdings, Inc. was founded in 1946 and is headquartered in Northbrook, Illinois.

Pfizer stock logo

Pfizer NYSE:PFE

$24.30 -0.41 (-1.64%)
Closing price 03:59 PM Eastern
Extended Trading
$24.30 +0.00 (+0.00%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.